GlassScriptPhysician profile
Andrew J Glick
NPI 1356399935
$747.69
in general payments reported to CMS, 2019-2025
16 companies · $92.54 in 2025
The $92.54 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.51 · 2020: $18.81 · 2021: $84.78 · 2022: $172 · 2023: $215 · 2024: $148 · 2025: $92.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $390 · Education: $65.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $390.26 |
| Education | $65.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $96.52 | 2019-2024 | |
| Progenics Pharmaceuticals, INC. | $93.64 | 2023-2024 | Pylarify |
| Merck Sharp & Dohme LLC | $89.16 | 2023-2025 | Keytruda, Lynparza |
| Palette Life Sciences, INC. | $84.20 | 2022 | |
| Baxter Healthcare | $60.00 | 2024 | Floseal |
| Astellas Pharma US INC | $55.96 | 2021-2023 | Xtandi |
| Amgen INC. | $52.67 | 2021-2022 | |
| Dentsply Ih Ab | $42.89 | 2023 | Lofric |
| Astrazeneca Pharmaceuticals LP | $32.61 | 2023-2025 | Lynparza |
| Novartis Pharmaceuticals Corporation | $29.59 | 2023 | |
| Allergan, INC. | $24.50 | 2021 | |
| Axonics, INC. | $22.41 | 2024 | Axonics |
| Urogen Pharma, INC. | $18.81 | 2020 | |
| Myovant Sciences INC. | $16.54 | 2022 | |
| Teleflex LLC | $14.41 | 2025 | Barrigel |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Photocure INC | $13.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Glick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.